AllianceBernstein
BBNX

AllianceBernstein’s Beta Bionics BBNX Stock Holding History

AllianceBernstein’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$567K Buy
56,600
+21,200
+60% +$252K ﹤0.01% 2638
2026
Q1 		$1.08M Hold
35,400
– – ﹤0.01% 2312
2025
Q4 		$1.08M Buy
35,400
+10,900
+44% +$291K ﹤0.01% 2309
2025
Q3 		$487K Sell
24,500
-168,825
-87% -$2.97M ﹤0.01% 2697
2025
Q2 		$2.81M Sell
193,325
-903,938
-82% -$12.8M ﹤0.01% 1764
2025
Q1 		$13.4M Buy
+1,097,263
New +$20.5M ﹤0.01% 1024

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AllianceBernstein's BBNX Position: Q2 2026 in Review

AllianceBernstein increased its Beta Bionics (BBNX) stake by 60% in Q2 2026, buying an estimated $252K and bringing the position to 56,600 shares worth $567K. The position accounts for ﹤0.01% of the portfolio, ranked #2638.

AllianceBernstein first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $13.4M in Q1 2025. 134 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • AllianceBernstein held 56,600 shares of Beta Bionics worth $567K as of Q2 2026.
  • AllianceBernstein bought 21,200 Beta Bionics shares in Q2 2026, an estimated $252K.
  • Beta Bionics made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2638 holding.
  • AllianceBernstein first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • AllianceBernstein's Beta Bionics position peaked at $13.4M in Q1 2025.
  • 134 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.